Regardless of the mechanisms, the findings that there are cases of collapsing FSGS in AA and non-AA patients with COVID-19 and low risk APOL1 variants suggest that it would be misleading to assume that everyone with this disease has APOL1 high-risk variants. The gene discussed is APOL1; the disease is COVID-19.